News
ArrivoBio Raises $45M in Series B Financing to Advance Pipeline
Arrivo BioVentures today announced the closing of an oversubscribed Series B preferred financing round, totaling $45.25 million in committed capital, bringing the total raised since the company’s inception to $100M.